Effect of Domperidone on QT Interval in Premature Infants
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
30 premature infants treated by domperidone upon decision of the attending neonatologist will
have a daily recording of electrocardiogram for the first 7 seven days of treatment, and
pharmacokinetics dosages at Day 7. Their ECG will be compared to 30 non treated premature
infants, matched for gestational age, postnatal age and sex.